Split designed to achieve compliance with Nasdaq minimum bid price requirements BOSTON, May 2, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics,...
Read More Details
Finally We wish PressBee provided you with enough information of ( TransCode Therapeutics Announces 1-for-28 Reverse Stock Split )
Also on site :
- Michael J. Fox Fans Send Love After Rare Appearance Using Wheelchair
- James B. Milliken, University of Texas chancellor, named University of California president
- Market volatility to stay due to geopolitical tensions, Q4 earnings season: Analysts